Q1 2014

Source filing unavailable

Q1 2014 · —

Revenue

$53.88M

+25.0% vs Q1 2013

Net Income

-$20.24M

N/M vs Q1 2013

EPS Diluted

-$0.55

N/M vs Q1 2013

Operating Income-$25,458,000N/M

Operating Cash Flow-$29,245,000N/M

Free Cash Flowderived

Same quarter

Metric	Q1 2014	Q1 2013	Q1 2012	Q1 2011
Revenue	$53.88M	$43.10M	$50.31M	$18.53M
Net Income	-$20.24M	-$8.06M	-$6.83M	-$21.40M
EPS Diluted	-$0.55	-$0.22	-$0.19	-$0.61

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR